Gilead Announces Phase 3 Results for ... - HFI Connect - Hep...

HFI Connect - Hepatitis

920 members1,209 posts

Gilead Announces Phase 3 Results for Genvoya® (Elvitegravir, Cobicistat, etc.), an Investigational Once-Daily Single Tablet Regimen for HIV

kcohen
kcohen

natap.org/2015/EACS/EACS_01...